SCHEMBL5589467

SCHEMBL5589467

CC(=Nc1ccc(C)cc1C)c1ccc(C(C)=Nc2ccc(C)cc2C)o1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.47
MAPT P10636 5/20 0.47
MEN1 O00255 4/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 5/20 0.40
CYP3A4 P08684 1/20 0.40
ADRA2A P08913 1/20 0.40
HTT P42858 3/20 0.38
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
TP53 P04637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GAA P10253 5/20 0.36
HPGD P15428 2/20 0.36
THRB P10828 2/20 0.36
POLB P06746 1/20 0.36
PKM P14618 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589462 1.00 KMT2A (0.47) KMT2AMAPTMEN1NPC1RAB9A
SCHEMBL5587365 0.80 TRPA1 (0.40) KMT2AMAPTMEN1NPC1RAB9A
SCHEMBL5589111 0.78 SIGMAR1 (0.47) KMT2AMAPTMEN1NPC1RAB9A
SCHEMBL5589831 0.78 GAA (0.34) KMT2AMEN1ALDH1A1TP53TDP1
SCHEMBL5589108 0.78 SIGMAR1 (0.47) KMT2AMAPTMEN1NPC1RAB9A
SCHEMBL5589828 0.78 GAA (0.34) KMT2AMEN1ALDH1A1TP53TDP1
SCHEMBL15291795 0.77 NPC1 (0.52) KMT2AMAPTMEN1NPC1RAB9A
SCHEMBL15944590 0.77 NPC1 (0.52) KMT2AMAPTMEN1NPC1RAB9A
SCHEMBL21251193 0.75 MAPT (0.54) KMT2AMAPTMEN1NPC1RAB9A
SCHEMBL5589348 0.75 MAPT (0.54) KMT2AMAPTMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 KMT2A 1733/4885MAPT 585/4885MEN1 3377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.